NADEJDA DOBRYDNIK: Open Payments
NPI 1003329038 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 50 payments from 9 companies in 2025. Trend: 2023 $1,027 · 2024 $1,163 · 2025 $1,417
Food & beverage: $1,417
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 28 | $875 |
| Gilead Sciences, Inc. | 13 | $334 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| Exact Sciences Corporation | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: APRETUDE, DOVATO, CABENUVA, Biktarvy, PIFELTRO, CAPVAXIVE, Cologuard Collection Kit, FLUZONE HIGH-DOSE.
Industry payments across FL — which companies pay providers there.
